Neuronetics, Inc. (STIM)

USD 1.37

(5.38%)

Gross Profit Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual gross profit in 2023 was 51.7 Million USD , down -0.05% from previous year.
  • Neuronetics, Inc.'s latest quarterly gross profit in 2024 Q2 was 11.62 Million USD , down -2.79% from previous quarter.
  • Neuronetics, Inc. reported a annual gross profit of 49.72 Million USD in annual gross profit 2022, up 13.89% from previous year.
  • Neuronetics, Inc. reported a annual gross profit of 43.65 Million USD in annual gross profit 2021, up 15.84% from previous year.
  • Neuronetics, Inc. reported a quarterly gross profit of 12.52 Million USD for 2024 Q1, down -17.95% from previous quarter.
  • Neuronetics, Inc. reported a quarterly gross profit of 11.76 Million USD for 2023 Q3, down -7.91% from previous quarter.

Annual Gross Profit Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Gross Profit of Neuronetics, Inc. (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 51.7 Million USD -0.05%
2022 49.72 Million USD 13.89%
2021 43.65 Million USD 15.84%
2020 37.69 Million USD -20.26%
2019 47.26 Million USD 17.2%
2018 40.32 Million USD 30.93%
2017 30.8 Million USD 11.57%
2016 27.6 Million USD 0.0%

Peer Gross Profit Comparison of Neuronetics, Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD -440.508%
Prenetics Global Limited 8.82 Million USD -485.568%
Star Equity Holdings, Inc. 11.92 Million USD -333.549%
CareDx, Inc 178.32 Million USD 71.005%
Exact Sciences Corporation 1.84 Billion USD 97.198%
Exagen Inc. 29.45 Million USD -75.533%
Inotiv, Inc. 165.44 Million USD 68.748%
Guardant Health, Inc. 336.89 Million USD 84.653%
Biodesix, Inc. 36.07 Million USD -43.318%
BioNexus Gene Lab Corp. 1.32 Million USD -3789.062%
Precipio, Inc. 6.01 Million USD -759.172%
iSpecimen Inc. 5.1 Million USD -912.252%
Natera, Inc. 492.74 Million USD 89.507%
Aspira Women's Health Inc. 5.26 Million USD -882.611%
Standard BioTools Inc. 50.45 Million USD -2.488%
23andMe Holding Co. 99.37 Million USD 47.971%
Castle Biosciences, Inc. 174.8 Million USD 70.421%
Personalis, Inc. 18.2 Million USD -183.969%
Aclaris Therapeutics, Inc. 13.16 Million USD -292.656%
Applied DNA Sciences, Inc. 5.53 Million USD -834.411%
OpGen, Inc. -90.69 Thousand USD 57110.387%
T2 Biosystems, Inc. -8.17 Million USD 732.864%
Myriad Genetics, Inc. 476.4 Million USD 89.147%
ICON Public Limited Company 1.81 Billion USD 97.15%
NeoGenomics, Inc. 244.6 Million USD 78.862%
Star Equity Holdings, Inc. 11.92 Million USD -333.549%
IDEXX Laboratories, Inc. 2.18 Billion USD 97.639%
RadNet, Inc. 93 Million USD 44.403%
MDxHealth SA 43.92 Million USD -17.701%
Psychemedics Corporation 8.41 Million USD -514.585%
Illumina, Inc. 2.74 Billion USD 98.116%
Check-Cap Ltd. -212 Thousand USD 24489.151%
Twist Bioscience Corporation 133.34 Million USD 61.226%
DarioHealth Corp. 5.98 Million USD -764.054%
Fulgent Genetics, Inc. 104.45 Million USD 50.501%
Sera Prognostics, Inc. 96 Thousand USD -53759.375%
ENDRA Life Sciences Inc. -275.45 Thousand USD 18871.034%
OPKO Health, Inc. 318.12 Million USD 83.747%
Medpace Holdings, Inc. 524.5 Million USD 90.142%
Neogen Corporation 463.9 Million USD 88.854%
Intelligent Bio Solutions Inc. 1.42 Million USD -3526.828%
Prenetics Global Limited 8.82 Million USD -485.568%
Mainz Biomed B.V. 509.65 Thousand USD -10045.019%
bioAffinity Technologies, Inc. 791.61 Thousand USD -6431.584%
Trinity Biotech plc 19.45 Million USD -165.835%
Sotera Health Company 577.15 Million USD 91.041%
bioAffinity Technologies, Inc. 791.61 Thousand USD -6431.584%